Literature DB >> 16328962

Enhanced lutein bioavailability by lyso-phosphatidylcholine in rats.

R Lakshminarayana1, M Raju, T P Krishnakantha, V Baskaran.   

Abstract

The bioavailability of lutein solubilized in mixed micelles containing either phosphatidylcholine (PC) or lysophosphatidylcholine (lysoPC) was evaluated in male rats. Mixed micelles contained 2.5 mM monooleoylglycerol, 7.5 mM oleic acid, 12 mM sodium taurocholate and 200 microM lutein either with 3 mM PC or lysoPC. To study lutein bioavailability, single and repeated dose experiments were conducted. For single dose study, group of rats (n = 30/group) were fed single dose of lutein solubilized in lysoPC (LPC group), PC (PC group) and no phospholipids (NoPL group) in micellar form. Each group was further divided in to five sub-groups (n = 6/sub group) to measure lutein bioavailability over time up to 9 h. For repeated dose study, group of rats (n = 6/group) were fed daily for 10 days a dose of lutein in mixed micelles with NoPL, PC and LPC. A separate group (n = 6) not fed mixed micelles was considered as zero-time control. In both the experiments, mixed micelles (0.2 ml/rat) were fed to the rat by direct intubation to the stomach. Results of single dose studies showed that the mean lutein levels in the plasma and liver of the PC group was significantly lower (p < 0.05) than those of the other two groups. Moreover, the average lutein level in the plasma and liver was significantly (p < 0.05) different among the groups in the order LPC > NoPL > PC. But, repeated dose experiment followed the order LPC > PC > NoPL. The level of lutein excreted through urine and feces of PC group was significantly higher (p < 0.05) than those of the other two groups. Thus, the results indicate that the PC in the mixed micelles suppressed the intestinal uptake of lutein after single dose but not after repeated dose and that lysoPC enhanced the absorption. In both the experiments, plasma and liver level of lutein was higher in LPC compared with PC group. Results also suggest that the luminal hydrolysis of PC to lysoPC is necessary for intestinal uptake of lutein solubilized in mixed micelles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16328962     DOI: 10.1007/s11010-006-1337-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Phosphatidylcholine inhibits and lysophosphatidylcholine enhances the lymphatic absorption of alpha-tocopherol in adult rats.

Authors:  S I Koo; S K Noh
Journal:  J Nutr       Date:  2001-03       Impact factor: 4.798

2.  Estimation of carotenoid accessibility from carrots determined by an in vitro digestion method.

Authors:  E Hedrén; V Diaz; U Svanberg
Journal:  Eur J Clin Nutr       Date:  2002-05       Impact factor: 4.016

3.  Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk.

Authors:  G J Handelman; Z D Nightingale; A H Lichtenstein; E J Schaefer; J B Blumberg
Journal:  Am J Clin Nutr       Date:  1999-08       Impact factor: 7.045

4.  Distribution of orally administered beta-carotene among lipoproteins in healthy men.

Authors:  E J Johnson; R M Russell
Journal:  Am J Clin Nutr       Date:  1992-07       Impact factor: 7.045

5.  Content of phospholipids in human diets studied by the duplicate-portion technique.

Authors:  B Akesson
Journal:  Br J Nutr       Date:  1982-03       Impact factor: 3.718

6.  Kinetic characteristics of beta-carotene uptake and depletion in rat tissue.

Authors:  S S Shapiro; D J Mott; L J Machlin
Journal:  J Nutr       Date:  1984-10       Impact factor: 4.798

7.  Effects of dietary polyenylphosphatidylcholine on metabolism of cholesterol and triglycerides in hypertriglyceridemic patients.

Authors:  Y A Kesaniemi; S M Grundy
Journal:  Am J Clin Nutr       Date:  1986-01       Impact factor: 7.045

8.  Phospholipase A2 relieves phosphatidylcholine inhibition of micellar cholesterol absorption and transport by human intestinal cell line Caco-2.

Authors:  R Homan; K L Hamelehle
Journal:  J Lipid Res       Date:  1998-06       Impact factor: 5.922

9.  Bioavailability of lutein in humans from intrinsically labeled vegetables determined by LC-APCI-MS.

Authors:  Annette Lienau; Tobias Glaser; Guangwen Tang; Gregory G Dolnikowski; Michael A Grusak; Klaus Albert
Journal:  J Nutr Biochem       Date:  2003-11       Impact factor: 6.048

10.  Comparative absorption and transport of five common carotenoids in preruminant calves.

Authors:  T L Bierer; N R Merchen; J W Erdman
Journal:  J Nutr       Date:  1995-06       Impact factor: 4.798

View more
  6 in total

1.  Single oral dose of micellar β-carotene containing phospholipids improves β-carotene metabolism and plasma lipids in vitamin A-deficient rats.

Authors:  Raju Marisiddaiah; Lakshminarayana Rangaswamy; Baskaran Vallikannan
Journal:  Eur J Nutr       Date:  2010-12-25       Impact factor: 5.614

2.  Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model.

Authors:  Gurunathan Sharavana; G S Joseph; Vallikannan Baskaran
Journal:  Eur J Nutr       Date:  2016-08-03       Impact factor: 5.614

3.  Phospholipid, oleic acid micelles and dietary olive oil influence the lutein absorption and activity of antioxidant enzymes in rats.

Authors:  R Lakshminarayana; M Raju; M N Keshava Prakash; V Baskaran
Journal:  Lipids       Date:  2009-08-14       Impact factor: 1.880

4.  Effect of mono- and diglycerides on the digestion and absorption of lutein in lymph fistula rats.

Authors:  Patrick Tso; Mustafa Vurma; Chih-Wei Ko; Dana Lee; Stephen DeMichele
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-02-22       Impact factor: 4.052

Review 5.  Bioactive Egg Components and Inflammation.

Authors:  Catherine J Andersen
Journal:  Nutrients       Date:  2015-09-16       Impact factor: 5.717

6.  Self-nanoemulsifying drug delivery system of lutein: physicochemical properties and effect on bioavailability of warfarin.

Authors:  Juno Yoo; Rengarajan Baskaran; Bong-Kyu Yoo
Journal:  Biomol Ther (Seoul)       Date:  2013-03       Impact factor: 4.634

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.